John M Ndungu Selected Research

phenylalanyl-phenylalanyl-arginine chloromethyl ketone

4/2015	Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.
1/2014	Tumor angiogenesis therapy using targeted delivery of Paclitaxel to the vasculature of breast cancer metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John M Ndungu Research Topics

Disease

3	Neoplasms (Cancer) 04/2015 - 04/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2015
1	Glioma (Gliomas) 04/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Malaria 04/2006

Drug/Important Bio-Agent (IBA)

3	Paclitaxel (Taxol)FDA LinkGeneric 04/2015 - 04/2010
3	Thromboplastin (Tissue Factor)IBA 04/2015 - 04/2010
3	Pharmaceutical PreparationsIBA 01/2014 - 04/2006
2	phenylalanyl-phenylalanyl-arginine chloromethyl ketoneIBA 04/2015 - 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015
1	CY5.5 cyanine dyeIBA 04/2015
1	AntibodiesIBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 04/2015
1	Factor VIIa (Activated Factor VII)IBA 04/2015
1	LuciferasesIBA 01/2014
1	LactonesIBA 04/2006
1	artemisinin (artemisinine)IBA 04/2006
1	Antimalarials (Antimalarial Agents)IBA 04/2006
1	Malaria VaccinesIBA 04/2006
1	SesquiterpenesIBA 04/2006

Therapy/Procedure

2	Therapeutics 04/2015 - 01/2014
1	Intravenous Injections 01/2014